Welcome to our dedicated page for Credo Technology Group Holding SEC filings (Ticker: CRDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Credo Technology Group Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Credo Technology Group Holding's regulatory disclosures and financial reporting.
Credo Technology Group (CRDO) reported insider activity: a director and Chief Operating Officer sold 80,000 ordinary shares on 10/01/2025 in multiple trades under a Rule 10b5-1 trading plan adopted on July 2, 2025.
The sales were executed at weighted average prices between $141.6018 and $145.1814, with trade ranges from $141.01 to $145.60. Following these transactions, the reporting person beneficially owned 920,000 shares indirectly via Zhan BVI Co Ltd, 125,000 shares indirectly via EZ Trust, and 2,628,403 shares directly. The filing notes that indirect holdings are disclaimed except to the extent of any pecuniary interest.
Credo Technology Group Holding Ltd (CRDO) filed a Form 144 disclosing a proposed sale of 230,000 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $33,490,300.00 and approximately 172,995,595 shares outstanding. The shares were acquired on 11/12/2014 as private/founders' shares from the issuer and payment was recorded on the same date. The filing reports no securities sold in the past three months by the filing person. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information and references Rule 10b5-1 trading plans but does not provide a plan adoption date or additional remarks.
Cheng Chi Fung, listed as Director and Chief Technology Officer of Credo Technology Group Holding Ltd (CRDO), reported multiple sales of ordinary shares executed on 09/22/2025 under a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on 09/06/2024. The Form 4 records aggregated disposals of 114,430 ordinary shares in multiple transactions at weighted-average prices shown per tranche, with individual tranche averages ranging from about $160.71 to $175.52. After these sales the reporting person (indirectly through the Cheng Huang Family Trust) is shown as beneficially owning approximately 6,943,961 ordinary shares. The filings state the trust structure (trustees and beneficiaries) and include an undertaking to provide transaction-level price and share details on request. The form is signed by attorney-in-fact James Laufman on 09/24/2025.
Tan Lip Bu, a director of Credo Technology Group Holding Ltd (CRDO), reported a sale of ordinary shares executed on 09/18/2025. The filing shows 20,000 shares sold at a weighted average price of $175.1239 per share. After the reported transactions, the reporting person beneficially owns 422,180 ordinary shares indirectly, including 133,583 shares held through Walden Technology Ventures II LP and 39,736 shares held via the Lip-Bu Tan and Ysa Loo Trust. The filing also notes a 53,574-share disposition by A&E Investment LLC. The Form 4 was signed by an attorney-in-fact on 09/22/2025.
Credo Technology Group Holding Ltd (CRDO) insider sale summary: On 09/16/2025 William J. Brennan, who is President, CEO and a director, reported multiple open-market sales totaling 68,016 ordinary shares. The sales were executed in tranches at weighted-average prices ranging from about $160.80 to $167.78 per share and were effected under a Rule 10b5-1 trading plan adopted April 15, 2025. After the transactions, the reporting person directly owned 369,173 shares and indirectly (through The Brennan Family Trust dated 09/06/2002) had beneficial ownership of 1,992,502 shares, with the reporting person disclaiming beneficial ownership except to the extent of pecuniary interest.
Credo Technology Group Holding Ltd (CRDO) Rule 144 notice reports a proposed sale of 20,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $3,502,478, to be sold on 09/18/2025 on NASDAQ. The shares were acquired from the issuer on 12/20/2020 in a private issuance and paid for in cash. The filing also lists four prior sales by the related holder WALDEN TECHNOLOGY VENTURES II LP during the past three months, totaling 171,545 shares and gross proceeds of approximately $17,303,100. The filer certifies no undisclosed material adverse information and includes broker details and transaction dates.
Cheng Chi Fung, Chief Technology Officer and director of Credo Technology Group Holding Ltd (CRDO), reported multiple sales of the issuer's ordinary shares on 09/15/2025. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on 09/06/2024. The Form 4 lists a series of dispositions in multiple trades with weighted-average prices for each lot (ranges provided for each lot), including listed disposals totaling 55,000 shares across several price bands and an additional line showing 114,430 shares disposed. Post-transaction beneficial ownership figures are shown declining to 6,998,961 shares (indirectly held through the Cheng Huang Family Trust). The form was signed by an attorney-in-fact on 09/17/2025.
Reporting person Lip-Bu Tan (a Credo Technology Group Holding Ltd director) reported two open-market sales on 09/12/2025 totaling 25,000 ordinary shares sold in multiple trades at weighted average prices of $161.5278 and $162.3665. The filing shows the sales reduced two indirect holdings to 455,608 and 442,180 shares respectively. The report also discloses additional indirect holdings of 133,583 shares (Lip-Bu Tan and Ysa Loo Trust) and 39,736 shares (A&E Investment LLC), plus 53,574 shares held directly. The form includes explanations of price ranges and updated entity names for the disclosed funds.
Credo Technology Group Holding Ltd (CRDO) filing reports a proposed sale under Rule 144 of 77,492 Class A common shares through Goldman Sachs & Co. LLC with an aggregate market value of $12,346,025.44. The filing shows the seller acquired 50,000 shares in a private issuance on 01/31/2022 and 27,492 shares as restricted stock unit compensation on 01/27/2022. An approximate sale date is listed as 09/11/2025 and the shares trade on NASD with 171,641,835 shares outstanding. The filing also lists multiple related sales in the past three months by entities named The Brennan Family Trust and William Joseph Brennan III totaling material share dispositions.
Cheng Chi Fung, Chief Technology Officer and director of Credo Technology Group Holding Ltd (CRDO), reported multiple dispositions of ordinary shares on 09/08/2025 executed under a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on 09/06/2024. The Form 4 shows a series of sales at weighted-average prices across price bands from $141.52 to $149.02, with the reported total disposition shown as 114,430 shares. After these transactions, the reporting person beneficially owned 7,053,961 ordinary shares indirectly through the Cheng Huang Family Trust, of which he and his spouse are trustees and beneficiaries.